These adaptable tools support primary care practices in universal T1D screening and ongoing monitoring. Explore clinician conversation guides, clinical protocols, family handouts, and result resources organized by audience and pathway moment.
The SPOT-T1D Kids Implementation Guide and embedded toolkit of resources provides evidence-based guidance for primary care teams to plan, launch, improve, and sustain pediatric type 1 diabetes (T1D) autoantibody screening and monitoring in their clinics.
Francine Maloney, MPH and Umila Singh, MFA author a perspective published by Breakthrough T1D on the development of the recently released SPOT-T1D Kids clinical pathway, tools, and implementation guide.
Tricia Vallabhaneni, MBA, M.Ed, PMP, is a Senior Project Manager at Ariadne Labs. She brings extensive experience leading projects across the Ariadne arc, guiding multidisciplinary teams from early innovation through implementation and spread. Drawing on a strong background in operational leadership and project governance—including prior roles at Northeastern University—Tricia specializes in workflow optimization, project plan… Continue reading Tricia Vallabhaneni
SPOT-T1D Kids Implementation Guide & Toolkit The SPOT-T1D Kids Implementation Guide and embedded toolkit of resources provides evidence-based guidance for primary care teams to plan, launch, improve, and sustain pediatric type 1 diabetes (T1D) autoantibody screening and monitoring in their clinics. Explore the practical resources below – organized in the four phases – and review… Continue reading SPOT-T1D Kids Implementation Guide & Toolkit
Ariadne Labs formed the United States (U.S.) Coalition for Early T1D Action in 2025 to develop a practical, evidence-informed clinical pathway for T1D autoantibody screening and follow-up care. Launched in 2025, the coalition brought together 25 clinicians, researchers, health system leaders, and patient and family representatives from across the U.S. The coalition’s key goals were… Continue reading The Coalition
Strategy for Spread Screening Every Child for T1D – Strategy for Spread To help ensure this coordination occurs efficiently, the Coalition has created this Spread Strategy, a document that identifies key system and environmental areas of focus for scaling, next steps to address those areas, and relevant stakeholders to take ownership of next steps.
Ariadne Labs releases landscape report; launches Coalition for action on type 1 diabetes risk screening For most children with type 1 diabetes, diagnosis occurs only after a serious medical event. Warning signs can be subtle and easy to miss until they become severe, and many children are only diagnosed once admitted to the hospital already… Continue reading Scaling Screening for Type 1 Diabetes Risk
Ariadne Labs, with funding from The Leona M. and Harry B. Helmsley Charitable Trust, has conducted comprehensive follow-up research in the area of Type 1 diabetes screening. We have compiled this report to share findings on further progress in advancing screening and identify priorities for future work.
Umila Singh, MFA is a Design Specialist at Ariadne Labs. In this role, she serves as an innovation and design content expert for the Lab, supporting projects to design effective improvement solutions that meet people’s needs and improve their lives. Her professional background includes working as a Senior Innovation Strategist for a safety-net hospital in… Continue reading Umila Singh